A year after posting his first ever annual loss, Brazilian hedge fund manager Rogerio Xavier pulled off a comeback. The 58-year investor, one of the founders of SPX Capital, saw the SPX Raptor fund — a more aggressive version of its flagship Nimitz offering — top 96% of peers tracked by Bloomberg last year. The fund jumped 22% after fees.
Open FlipViva Wallet's backers sold a✅ 45% stake to JPMorgan for ✅$856 million in 2022, with a deal that included options for JPMorgan to buy the rest, valuing the company at $5 billion. However, the fintech crash and regulatory issues have led to a bitter dispute, with both sides suing each other in London.
Open FlipBristol Myers Squibb Co. said its new schizophrenia drug is off to a better start than similar recently launched treatments, in an early sign that its $14 billion purchase of Karuna Therapeutics is paying off. The medication, to be sold under the name Cobenfy, was a key piece of Bristol’s acquisition of Karuna.
Open Flip